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ABBREVIATIONS 
Π, surface pressure; al-PC, 1-palmitoyl-2-[16-(acryloyloxy)hexadecanoyl]-sn-glycero-3-
phosphorylcholine; APM, area per molecule; ATP, adenosine triphosphate; CFU, colony 
forming units; Chol, cholesterol; CHX, chlorhexidine; CL, cardiolipin; CW, central water; 
D2O, deuterium oxide; d62DPPC, 1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine; 
d62DPPG, 1,2-dipalmitoyl-d62-sn-glycero-3-phospho-(1'-rac-glycerol); DiSC3(5), 3,3′-
dipropylthiadicarbocyanine iodide; DMSO, dimethyl sulfoxide; LB, Langmuir-Blodgett; L-
PG, lysyl-phosphatidylglycerol; LS, Langmuir-Schafer; MIC, minimum inhibitory 
concentration; MRSA, methicillin resistant Staphylococcus aureus; MV, molecular volume; 
NR, neutron reflectometry; Pen G, penicillin G; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine; POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol); SAM, 
self-assembled monolayers; SLD, scattering length density; SMW, silicon matched water; 
SSI, surgical site infections; SRS, standard reaction solution; TMPA, 3-
(trimethoxysilyl)propyl acrylate; TSA, tryptone soya agar. 
  
ABSTRACT 
HT61 is a quinoline-derived antimicrobial, which exhibits bactericidal potency against both 
multiplying and quiescent methicillin resistant and sensitive Staphylococcus aureus, and has 
been proposed as an adjunct for other antimicrobials in order to extend their usefulness in the 
face of increasing antimicrobial resistance. In this study we have examined HT61’s effect on 
the permeability of Staphylococcus aureus membranes and whether this putative activity can 
be attributed to an interaction with lipid bilayers. Using membrane potential and ATP release 
assays, we have shown that HT61 disrupts the membrane enough to results in depolarisation 
of the membrane and release of intercellular constituents at concentrations above and below 
the minimum inhibitory concentration of the drug. Utilising both monolayer subphase 
injection and neutron reflectometry we have shown that increasing the anionic lipid content 
of the membrane leads to a more marked effect of the drug. In bilayers containing 25 mol% 
phosphatidylglycerol, neutron reflectometry data suggests that exposure to HT61 increases 
the level of solvent in the hydrophobic region of the membrane, which is indicative of gross 
structural damage. Increasing the proportion of PG elicits a concomitant level of membrane 
damage resulting in almost total destruction when 75 mol% phosphatidylglycerol is present. 
We therefore propose that HT61’s primary action is directed towards the cytoplasmic 
membrane of Gram positive bacteria. 
 
  
The quinoline-derived cationic antimicrobial HT61 [1] was initially developed to improve the 
success of nasal decolonisation interventions aimed at decreasing the risk of post-operative 
surgical site infections (SSI) posed by carriage of methicillin resistant Staphylococcus aureus 
(MRSA) [2, 3].  However, more recently it has been proposed as a resistance breaker to be used 
in conjunction with other more established antimicrobials [4]. Although the protein synthesis 
inhibitor mupirocin is currently widely used for anti-MRSA nasal decolonisation, it is not 
active against non-multiplying persister bacteria which constitute a reservoir for 
recolonisation [5]. In addition to this, an increased prevalence of mupirocin resistant MRSA [6] 
has led to the development of more effective alternatives, including the experimental 
antimicrobials LTX-109 [7] and XF-73 [8] in addition to HT61 [1].  
The mode of action of HT61 has not hitherto been thoroughly investigated, however initial 
cell-based assays showed that HT61 is capable of depolarising the cytoplasmic membrane of 
Gram positives with further evidence from electron microscopy suggesting that HT61 causes 
lysis of either the membrane or cell wall [1, 4]. The putative membrane-targeting of HT61 may 
provide some explanation for its potency against non-multiplying MRSA [9], and suggests 
that its mechanism of action may be similar to those of other membrane-active antibiotics 
such as daptomycin [10], cationic antibiotics such as polymyxins B and E (colistin), 
gramicidin S [11] and cationic antimicrobials, for example chlorhexidine [12] and ceragenins 
[13]. In general, membrane-active cationic antimicrobials are thought to act by either binding 
to the headgroups of anionic membrane lipids and disrupting lipid packing to elicit increased 
permeability of ions and cell metabolites, or to solubilise the membrane in a detergent-like 
manner [12].  
Initially we sought to further examine and confirm the proposed membrane disrupting 
capabilities of HT61 by employing two simple techniques to measure HT61’s ability to 
damage or increase the permeability of S. aureus membranes, a membrane potential assay 
and ATP release assay [14]. These techniques have previously been used to investigate the 
membrane-activity of daptomycin [15], chlorhexidine [16], ceragenins [13], telavancin [17] and 
oritavancin [18] in which it was determined that these antimicrobials have a direct action on 
bacterial membranes, resulting in membrane disruption, loss of membrane integrity and 
release of intracellular constituents.  
In order to examine the putative membrane active mechanism of HT61 more closely, we also 
assessed the drug’s affinity for simple staphylococcal-mimetic membrane models composed 
of synthetic phosphatidylcholines (PC) and phosphatidylglycerol (PG) lipids. The relative 
proportions of the major phospholipid species in S. aureus membranes are dependent upon 
culture conditions, but their ranges are approximately as follows; PG 30-60%, cardiolipin 
(CL) 5-10% and lysyl-phosphatidylglycerol (L-PG) 20-50%  [19-21]. The increased 
biosynthesis of L-PG induced by mild environmental acidity or the presence of cationic 
antimicrobial peptides, is thought to attenuate the activity of membrane-active cationic 
antimicrobials against S. aureus via membrane charge dampening [22]. However, in the 
stationary phase, S. aureus membranes contain lower quantities of L-PG [23], which is likely 
to exist in either a zwitterionic form, or in a cationic form which would be incorporated into a 
neutral ion pair with PG or CL [24]. To reduce the number of variables in our model systems, 
the single and paired neutral lipid components of the staphylococcal membrane were 
represented by PC, with the excess anionic lipid content represented by PG. 
An initial assessment of HT61s specificity against the simple staphylococcal membrane 
model was conducted by comparing the kinetics of its partitioning into lipid monolayers 
deposited at the air/water interface following subphase injection of the drug, before 
conducting the more detailed study of the effects of HT61 on lipid bilayers using solid/liquid 
interface neutron reflectometry (NR). The NR samples were prepared by deposition of 
various PC/PG mixtures onto lipid grafted silicon substrates to form floating bilayers, in 
order to ensure that their thermodynamic properties more closely resembled those of 
biomembranes [25]. Due to the need to maintain stable planar bilayers for the NR experiments, 
CL was excluded form the model lipid bilayers, because of its propensity to localise in 
domains with negative curvature [26]. The use of chain-deuterated lipids to form the bilayers 
provided some contrast with the hydrogenated HT61 allowing us to determine the nature of 
any structural effects on the bilayers elicited by drug/membrane interaction. The 
complementary biological and biophysical techniques employed in this study shed light on 
both the bactericidal membrane-active mechanism of HT61 [4] and its specificity against 
staphylococci and other bacteria. 
  
METHODS AND MATERIALS 
Materials 
The phospholipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) (>99%), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG) (>99%), 1,2-dipalmitoyl-
d62-sn-glycero-3-phosphocholine (d62DPPC) (>99%), 1,2-dipalmitoyl-d62-sn-glycero-3-
phospho-(1'-rac-glycerol) (d62DPPG) (>99%) and cholesterol (Chol) (>98%) were all 
obtained from Avanti Polar Lipids Inc. (Alabaster, AL, USA) Ultra-pure water was obtained 
from a Milli-Q 16 Ultra-pure water system (Merck Millipore, USA) at a specific resistivity of 
18.2 MΩ.cm. HEPES, glucose, 3,3′-dipropylthiadicarbocyanine iodide (DiSC3(5)), phosphate 
buffered saline (PBS), dimethyl sulfoxide (DMSO) and 99.9% isotopically pure deuterium 
oxide (D2O) were all obtained from Sigma Aldrich (Poole, Dorset, UK). Nutrient broth, iso-
sensitest broth and tryptone soya agar (TSA) all obtained from Oxoid (Basingstoke, 
Hampshire, UK). 
The antimicrobials were used as supplied, without any additional purification and were 
diluted in ultrapure water. The antimicrobials used, and their stock concentrations, were as 
follows; chlorhexidine diacetate (10 mg/ml), penicillin G (2 mg/ml) all Sigma Aldrich (Poole, 
Dorset, UK), daptomycin (10 mg/ml) (Cubicin, USA) and HT61 mesylate (10 mg/ml) 
(Helperby Therapeutics, UK). The use of daptomycin required supplementation with 50 mg/L 
calcium chloride. 
Bacterial Strain and Growth Conditions 
Oxford S. aureus (NCTC 6571) was grown at 37˚C in nutrient broth at 100 rpm for either 18 
hours (logarithmic growth phase) or 5 days (stationary growth phase).  
Determining Antimicrobial Minimum Inhibitory Concentrations 
Bacterial cultures were diluted to 0.05 OD600 (1x10
6 CFU/ml) in iso-sensitest broth, prior to 
triplicate 290 µl samples of the culture receiving 10 µl aliquots of the antimicrobials 
chlorhexidine, daptomycin, HT61 or penicillin G to make seven final concentrations ranging 
from 16-0.25 mg/L, 8-0.125 mg/L, 32-0.5 mg/L and 2-0.03 mg/L, respectively, in a 96-well 
microtitre plate. A blank sample of 300 µl iso-sensitest broth was added to one column and 
300 µl of the untreated culture was added to the last row of the 96-well microplate (VWR, 
UK) to serve as a negative and positive control and incubated for 18 hours at 37˚C. The 
minimum inhibitory concentration (MIC) for each antimicrobial was determined as the 
lowest concentration at which there was no visible bacterial growth. 
Membrane Potential Assay 
Bacterial cultures were grown to either exponential or stationary phase as described above, 
prior to dilution to 0.05 OD600 (1x10
6 CFU/ml). The potentiometric fluorescent probe 
DiSC3(5) was added to each culture at a final concentration of 0.8 µM, and was given 
sufficient time to accumulate in the plasma membranes of the cells. Using an opaque, black 
96-well microplate (Thermo Scientific, UK), 290 µl of the cell suspension with dye was 
added to the wells and the fluorescence intensity was measured using a Fusion 153601 
fluorescence microplate reader (Perkin Elmer, UK) at excitation and emission wavelengths of 
620 and 670 nm respectively, at 500 V and a gain setting of 1. In triplicate, 10 µl of the 
membrane-active biocide chlorhexidine, HT61 and the cell wall synthesis inhibitor penicillin 
G were added to the 290 µl cell suspension, making final concentrations of 32, 16, 8, 4, 2, 1 
and 0.5 mg/L. To the final well, 10 µl of HEPES buffer was added as a drug-free control. The 
fluorescence intensity of each well was measured after a 20 minute incubation with the 
antimicrobials. Fluorescence intensities from the blank measurements were subtracted from 
the final results and the control intensities were subtracted from each time point.[4] 
ATP Release Assay 
After incubation to either exponential or stationary phase, bacterial cultures were centrifuged 
at 3600 rpm for 20 minutes and washed three times in PBS, prior to re-suspension in HEPES 
buffer (5 mM HEPES, 5 mM glucose, pH 7.2) and dilution to 0.2 OD600 (1x10
8 CFU/ml). 
Chlorhexidine, HT61 and penicillin G were added to 0.5 ml of the bacterial suspensions in 
centrifuge tubes to give final drug concentrations of 16, 8, 4 or 2 mg/L with ultrapure water 
used as the negative control. The treated cultures were incubated for 20 minutes at room 
temperature, and then centrifuged at 13000 rpm for 5 minutes. Following centrifugation, 200 
µl of the supernatant was mixed with 200 µl of DMSO (to produce the extracellular sample) 
and the rest was discarded. The remaining pellet was re-suspended in 500 µl DMSO and 
incubated for 10 minutes at room temperature (to produce the intracellular sample), with 500 
µl HEPES buffer added after incubation. Using a black 96-well microplate, 10 µl of the 
intracellular sample and 10 µl of the extracellular sample were added to two separate wells 
containing 290 µl of the luciferase-containing standard reaction solution (SRS) made 
according to the ATP Determination Kit instructions (Invitrogen, UK). To a separate well, 10 
µl of 50% DMSO and 50% HEPES buffer was added to 290 µl of SRS. ATP-catalysed 
luciferase luminescence was then measured on a GloMax Multi+ microplate reader 
(Promega, UK). The blank sample luminescence was subtracted from all samples to mitigate 
the influence of natural release of ATP from the cell and the bioluminescence in 500 µl was 
calculated. 
Lipid Monolayer Drug Partitioning 
The effect of the subphase injection of HT61 on the surface pressure of biomimetic lipid 
monolayers was investigated using a custom-made polytetrafluoroethylene (PTFE) 110 cm3 
trough in combination with a Nima PS4 surface pressure microbalance (Nima Technologies 
Ltd., Coventry, U.K.) at 22°C. Three different monolayers were employed; a neutral lipid 
control consisting only of POPC, a mammalian membrane mimetic control containing a 
POPC/Chol 75:25 molar ratio mixture and a Staphylococcal mimetic POPC/POPG 75:25 
molar ratio mixture. In each case, the lipids were deposited at the air/water interface from 
solution in chloroform (2 mg/ml total lipid) until a surface pressure of between 30 – 35 mN/m 
was obtained. The surface pressure was continually monitored whilst the monolayer was 
allowed to achieve a stable surface pressure, before the injection into the subphase of 100 µl 
of HT61, from a syringe fixed prior to monolayer deposition, to give a final concentration of 
9.1 µg/ml. Surface pressure changes were continually recorded until a stable plateau was 
achieved.  
Nonlinear regression was applied to estimate the lag and slope of the Pressure-Time isotherm 
curves [27] generated after subphase injection of HT61. A general observation of the data is 
that the change in surface pressure (ΔΠ) follows a sigmoid increase over time. Both a three-
parameter Hill equation and a four-parameters sigmoidal function were used to fit the data 
depending on which gave a better fit according to the correlation coefficient obtained. The 
three-parameter Hill equation is described by the formula: 
∆Π =
∆Π𝑚𝑎𝑥∙𝑡
𝐻
𝑡50
𝐻 +𝑡𝐻
                                          (1) 
Where t represents the time, ΔΠmax denotes the maximum change in surface pressure, H is the 
Hill coefficient and t50 is the time taken to achieve 50% of the ΔΠmax.  
The four-parameters sigmoidal model is described by the following function: 
ΔΠ =ΔΠ0 +
ΔΠ𝑚𝑎𝑥−ΔΠ0
𝑒−(𝑡−𝑡50 𝐻⁄ )
                                  (2) 
Where ΔΠ0 denotes the minimum ΔΠ (lower plateau/asymptote).  
In both models the Hill coefficient describes the overall growth rate of the curve and is a 
measure of how quickly the curve moves from the lower asymptote to the upper asymptote.  
Neutron Reflectivity at the Solid/Liquid Interface  
The interaction of HT61 with the lipids of bacterial membrane mimetic bilayers was further 
investigated by solid/liquid interface neutron reflectometry using the D17 beamline at the 
Institut Laue-Langevin (Grenoble, France) [28]. The samples were deposited as bilayers onto 
silicon substrates measuring 50 × 80 × 10 mm (Crystran Ltd, Poole, UK), the single polished 
surface (5 Å RMS roughness tolerance) which had previously been functionalised with 
covalently bound 3-(trimethoxysilyl)propyl acrylate (TMPA) and 1-palmitoyl-2-[16-
(acryloyloxy)hexadecanoyl]-sn-glycero-3-phosphorylcholine (al-PC), based on the method of 
Hughes et al. [29]. This functionalised surface is henceforth referred to as the al-PC self-
assembled monolayer (al-PC SAM). Prior to bilayer deposition, the al-PC SAM layers where 
fully characterised on the D17 reflectometer at two different angles (0.8° and 3.2°) in H2O, 
silicon matched water (SMW) (62% v/v H2O and 38% D2O) and D2O contrasts.  
Bilayers consisting of d62DPPC and d62DPPG mixtures in molar ratios of 75:25, 50:50, and 
25:75 were deposited onto the al-PC SAMs by means of sequential Langmuir-Blodgett (LB) 
and Langmuir-Schafer (LS) techniques (ratio of 1:1), using a Nima 1212D Langmuir trough 
(Nima Technologies, UK) with an automated dipping mechanism [25]. The appropriate 
d62DPPC/d62DPPG mixtures were deposited onto an ultrapure water subphase from a 1 
mg/ml solution in chloroform, the solvent was allowed to evaporate and then the monolayer 
compressed to achieve a surface pressure of 28 mN/m at 25°C. A previously submerged 
SAM-coated silicon block was removed from the dipping well using the automated arm at a 
rate of 5 mm/minute, to deposit the inner leaflet of the d62DPPC/d62DPPG bilayer. To deposit 
the outer leaflet lipids, the silicon block was turned through 90°, so that the SAM and 
deposited inner leaflet were parallel with the water surface, and lowered back into the dipping 
well at a rate of 3 mm/minute. 
The floating bilayers were sealed, while still submerged, into their solid-liquid sample cells, 
to ensure that the SAM and bilayer were not exposed to air. The sample cell had two valves 
on opposite sides and a small reservoir inside (which was filled with water) to allow for 
solvent exchange during the reflectivity experiment. 
The cells containing the various SAM and bilayer combinations were mounted onto 
automated sample changer on the D17 reflectometer. The samples were characterised at 55°C 
(to ensure acyl chain fluidity and thus give results comparable with those obtained for the 
monolayer partitioning studies) at two different angles of 0.8° and 3.2°.  Neutron 
reflectometry data was collected again against three solvent contrasts; H2O, SMW and D2O. 
The solvents were exchanged automatically using a Knauer Smartline HPLC pump 1050 
(Berlin, Germany). After the characterisation of the bilayers, HT61 was added to the samples 
in two aliquots. Initially 10 ml of 1.67 µg/ml HT61 in H2O was pumped into each of cells and 
the data was collected in the same way as the sample characterisation outlined above. A 
further 20 ml of 1.67 µg/ml HT61, was pumped into each cell before further data collection. 
The data obtained from the neutron reflectivity measurements was analysed using custom 
procedures with the RasCAL software package [30]. The grafted al-PC SAM was 
characterised in the absence of the floating bilayers, by fitting them as a four layer model 
consisting of the following components extending from the silicon substrate; a layer of 
silicon oxide (SiO2), the TMPA linker layer, the al-PC hydrocarbon chains (al-PC Chains) 
and the al-PC headgroups (al-PC Heads). The scattering length density (SLD) values for each 
of these layers was fixed using values obtained from Hughes et al. [29]. The proportion of the 
silicon substrate which was covered by the SAM was determined by quantifying the solvent 
penetration into the al-PC chains region (Table S1). Solvent present in the al-PC layer would 
be expected to be displaced by lipid during the subsequent deposition of the floating bilayer. 
Thus an ‘al-PC filling in’ parameter is used when fitting the data obtained from the deposited 
floating bilayers. After deposition of the floating bilayer, the coverage of the SAM is 
therefore effectively 100% due to this filling of any inhomogeneity with the deposited lipids.  
The reflectivity curves obtained from the samples with floating bilayers were fitted 
simultaneously from the measurements recorded in each of the three different solvent 
contrasts (with the parameters for the al-PC SAM constrained by the fitted data for the 
substrate alone). The parameters used to fit the floating bilayer were the separation distance 
between the al-PC SAM and the deposited bilayer (Central Water or CW thickness), the area 
per molecule (APM) of the lipids in the deposited bilayer, the number of water molecules 
associated with the headgroups (H2Ohead) and the tails (H2Otail) of each lipid molecule and the 
roughness of the system (both local and global). This approach to fitting the data is more 
constrained by the physical parameters of the lipid membrane and requires fewer parameters 
to fit than a standard layer approach used elsewhere [31]. Parameterisation of building on the 
membrane has previously been discussed by Tatur et al. [32], here the number of water 
molecules per head and tail was calculated assuming that any change in the SLD of the layer 
towards the SLD of the solvent was due to penetration of the solvent into the layer. Using the 
number of water molecules (NW) per head and tail and the molecular volume of the lipids, 
the SLD of each layer in the bilayer was calculated using: 
SLD𝑙𝑎𝑦𝑒𝑟 =
∑ 𝑏𝑙𝑖𝑝𝑖𝑑+(NW𝑙𝑎𝑦𝑒𝑟∙𝑏𝑠𝑜𝑙𝑣𝑒𝑛𝑡)
∑ MV𝑙𝑖𝑝𝑖𝑑+(NW𝑙𝑎𝑦𝑒𝑟∙MV𝑠𝑜𝑙𝑣𝑒𝑛𝑡)
          (3) 
Further, the thickness of each layer was calculated from the APM and number of water 
molecules in the layer using: 
𝐿𝑙𝑎𝑦𝑒𝑟 =
∑ MV𝑙𝑖𝑝𝑖𝑑+(NW𝑙𝑎𝑦𝑒𝑟∙MV𝑠𝑜𝑙𝑣𝑒𝑛𝑡)
APM
           (4) 
where the molecular volumes (MV) and scattering cross sections (b) of each of the individual 
components in the system were calculated from literature values [33, 34].  
The additional tail hydration parameter, stated in Table 3, is a direct representation of the 
coverage of the floating bilayer and was calculated from the fitted parameters using the 
equation: 
Tail Hydration =
MV𝑠𝑜𝑙𝑣𝑒𝑛𝑡∙H2O𝑡𝑎𝑖𝑙
MV𝑡𝑎𝑖𝑙+(MV𝑠𝑜𝑙𝑣𝑒𝑛𝑡∙H2O𝑡𝑎𝑖𝑙)
×100      (5) 
where the percentage coverage of the floating bilayer is given by subtracting the Tail 
Hydration from 100. The errors stated are the result of Monte Carlo error analysis within 
RasCAL, known as ‘bootstrapping’ errors [35]. This approach to estimating errors involves 
finding the distribution of values for each parameter fitted as a function of the initial starting 
values. For all the errors presented the minimisation was repeated 200 times with randomised 
starting values fitted to a randomised number of points within the raw data, the standard 
deviation error of possible values for each parameter based on this was then found.  
RESULTS 
Minimum Inhibitory Concentrations 
The MICs for the antimicrobials used in this study were as follows; HT61 8 mg/L, 
chlorhexidine 4 mg/L, daptomycin 2 mg/L and penicillin G 0.5 mg/L. All the antimicrobials 
used during this study were therefore confirmed to have activity against S. aureus. The MIC 
of HT61 was higher in comparison to the other antimicrobials used, which was in agreement 
with the previously published MIC of HT61 against the same S. aureus strain.[1] 
Membrane Potential Assay 
Membrane depolarisation caused by structural perturbations, can be measured using the 
amphiphilic and cationic potentiometric fluorescent probe DiSC3(5). When partitioned into a 
cell membrane, DiSC3(5) fluorescence is quenched in the presence of a resting potential and 
once released back into free solution following membrane damage, the fluorescence is 
dequenched [36, 37].  
Both chlorhexidine and HT61 disrupted the S. aureus membranes to a large enough degree to 
cause depolarisation in both logarithmic (Fig. 1a) and stationary phase (Fig. 1b) cells in a 
concentration-dependent manner, a result which is consistent with previous findings [1, 16]. At 
the highest concentration used, penicillin G did not depolarise the S. aureus membranes (Fig. 
1) which is consistent with its mode of action requiring longer than 20 minutes to achieve cell 
lysis [14]. As the concentration of HT61 and chlorhexidine increases above the MIC, HT61 
caused a higher degree of depolarisation, and therefore we might surmise disrupted the 
membrane to a greater degree than chlorhexidine. 
To compare the rates of depolarisation (Vdep) of the different antimicrobials, the initial rate 
of depolarisation over the first minute after challenge was calculated and plotted against 
antimicrobial concentration, using a sigmoidal Hill function (eqn 6) fitted to the experimental 
data (using the non-linear curve fitting function in OriginLab Corp. Origin Pro 2016 Sr1):  
𝑉𝑑𝑒𝑝 =  𝑉𝑑𝑒𝑝𝑚𝑖𝑛 +
𝑉𝑑𝑒𝑝𝑚𝑎𝑥−𝑉𝑑𝑒𝑝𝑚𝑖𝑛 ∙ 𝐷
𝐻
𝐾𝑚
𝐻 + 𝐷𝐻
                        (6) 
As a means of comparing the activities of each drug, the maximum rate of depolarisation 
(Vdepmax) was determined in addition to the Michaelis-Menten constant (Km) which denotes 
the drug concentration (D) needed to achieve half of the maximum rate of depolarisation. The 
Hill coefficient (H) gives an indication of the overall rate of change across the full drug 
concentration range. The initial rate of depolarisation over the first minute for logarithmic 
and stationary phase S. aureus caused by chlorhexidine and HT61 was entirely concentration 
dependent (Fig. 2). Membrane disruption by HT61 depolarised the membranes of both the 
logarithmic (Vdepmax 21.0 s
-1, Km 5.8 μg/ml) and stationary phase (Vdepmax 10.9 s-1, Km 3.5 
μg/ml) S. aureus cells faster and to a greater degree than chlorhexidine did in each case, 
especially below the MIC (logarithmic phase; Vdepmax 6.3 s
-1, Km 11.8 μg/ml and stationary 
phase; Vdepmax 10.1 s
-1, Km 4.8 μg/ml). It is interesting to note that the activity of HT61 is 
attenuated to a greater degree in the stationary phase cells, compared to that of chlorhexidine.  
ATP Release Assay 
Substantial damage to cell membranes generally causes a rapid loss of large cellular 
components, such as ATP [14, 38]. As expected, penicillin G caused little to no release of ATP 
from the cells after 20 minutes (Fig. 3a and 3b), as this is not sufficient time for it to cause 
lysis through cell wall synthesis inhibition [14]. 
The membrane disruption caused by chlorhexidine and HT61, as indicated in the 
depolarisation assay, was indeed sufficient to induce the release of between approximately 
11% (at a concentration of 8 μg/ml chlorhexidine) and 71% ATP (at a concentration of 16 
μg/ml HT61) from logarithmic phase cells, but there was no release of ATP at lower 
concentrations (Fig. 3a). There was a larger degree of membrane disruption by HT61 and 
chlorhexidine towards stationary phase cells compared to logarithmic phase cells, resulting in 
a larger release of between approximately 36% and 88% ATP (Fig. 3b).  
Lipid Monolayer Drug Partitioning 
Having established that HT61 exhibits a lytic action on the S. aureus plasma membrane, from 
the results of biochemical whole cell based assays, the subsequent biophysical experiments 
using synthetic membrane mimetic models concentrated solely on examining this putative 
mode of action of HT61 in greater detail. There are marked differences in the kinetics of the 
interaction of subphase-injected HT61 and monolayers with different lipid compositions 
deposited at the air/water interface (Figure 4). The lack of any appreciable change in surface 
pressure when the net neutral charged POPC monolayer was exposed to HT61, indicates that 
charge plays an important role in initiating the interaction of the drug with lipid membranes. 
The addition of 25 mol% cholesterol to the POPC monolayer does elicit some interaction 
with HT61, which is sufficient to allow modelling of the kinetics with the three-parameter 
Hill function (equation 1). However, in the presence of sterol the maximum change in surface 
pressure for the POPC/Chol monolayers remained modest at 2.9 mN/m (Table 1) and the Hill 
coefficient of 1.04 indicates that the overall rate of surface pressure change is comparatively 
low. It is possible that some roughness of the monolayer caused by the inclusion of the sterol 
allows for some hydrophobic interaction with the HT61, which for the most part is sterically 
excluded from the interface by the presence of the cholesterol intercalated between the lipid 
molecules. Due to the minimal interaction HT61 had with the POPC and POPC/Chol 
monolayers, these lipid compositions were omitted from the subsequent neutron reflectivity 
experiments. 
The interaction of HT61 with the POPC/POPG monolayer is markedly different from its 
behaviour in the presence of the neutral monolayers. The inclusion of the anionic POPG in 
the monolayer resulted in a large increase in surface pressure following injection of the drug 
(Figure 4). The surface pressure changes elicited by the interaction show a biphasic pattern, 
the two phases of which were modelled in an overlapping piecewise fashion using both the 
three-parameter Hill function, between 0 and 35 s, and the four-parameter sigmoidal function 
(equation 2) between 17 and 300 s (Table 1). The biphasic nature of the interaction may 
result from the slow diffusion of the HT61 in the large bulk volume limiting the rate of 
partitioning during the first ~50 s post injection. Nevertheless when compared with the 
POPC/Chol monolayer, the HT61 interacts much faster with the POPC/POPG mixture and 
much more rapidly during the first phase (Hill coefficient 1.40). The maximum change in 
surface pressure of 13.7 mN/m, at the end of the second phase indicates that the monolayer 
allows the drug to partition and access the air/water interface at a very rapid rate (Hill 
coefficient 8.77). The main assumptions which can be drawn from these results are that it is 
the presence of the charged POPG that drives the initial attraction between the monolayer and 
the drug and encourages the partitioning of the drug via hydrophobic interactions.  
Neutron Reflectivity 
The fitted structural characteristics of each of the al-PC SAM layers used in this study are 
available to view in the supporting information. The grafted lipid coverage of each of the 
blocks was ~70%, as determined from the al-PC chains percentage hydration. The backfilling 
of regions not covered by the al-PC, which would have occurred by transfer from the lipid 
monolayer during the LB deposition step, was incorporated into the fitting for each of the 
floating bilayers, together with the fixed SAM parameters (Supporting Information). The 
values for the parameters used in the fitting of three floating d62DPPC/d62DPPG bilayers (Fig. 
5), together with those calculated using them (equations 3, 4 and 5), are compiled in Table 2. 
Characterisation of the floating bilayer before and after challenge with HT61 was performed 
at 55˚C to ensure that the bilayer lipids would be in the fluid phase, making the data obtained 
from the model comparable with those obtained from the POPC/POPG mixtures used in the 
monolayer study. It should be noted that the method used to fit the parameters of the floating 
bilayer, whereby reflectivity data obtained from three solvent contrasts (H2O, SWM and 
D2O) were fitted simultaneously (see Supporting Information Figs S2, S3 and S4), some 
deviation from the experimentally obtained curves is inevitable (Fig. 5). Although this serves 
to highlight that the parameters incorporated into the fitting routine may not have been 
entirely comprehensive, the error incurred nevertheless ensured that the fitted parameters 
were maintained within a physically reasonable range. 
There are three noteworthy effects of increasing the % d62DPPG in these bilayers. The 
separation between the SAM and the floating bilayer (CW thickness), was found to increase 
dramatically at and above 50 mol % d62DPPG. The reason for this increase is not clear, 
however it is of a magnitude similar to those found between bilayers of like charge [39]. The 
second noteworthy difference between the floating bilayers is in their calculated thicknesses, 
which decrease from ~44 Å in the 25 mol % d62DPPG to ~36 Å when the amount of 
d62DPPG was increased to 50 mol%. In the case of the 75 mol % d62DPPG the fitting 
suggests that there is significant thinning of the bilayer to ~28 Å which appears to be of a 
magnitude consistent with lipid chain interdigitation [40]. There is however, little difference in 
the calculated tail hydration, which can be used as a measure of floating bilayer integrity, 
since it suggests close to complete coverage for each of the lipid mixtures. Finally, the closest 
packed (based on APM) and lowest degree of undulation membrane (indicated by the global 
roughness) was found for the [50:50] d62DPPC/d62DPPG mixture. It might be suggested that 
this ratio of charged to zwitterionic species in the membrane offers the best packing of the 
lipids in this bilayer and thus the membrane fluctuations are reduced. However, this 
experimental data cannot shed any further light on to this phenomenon. 
The first clear effect of the interaction with the lipids of the bilayer following HT61 challenge 
is a consistent reduction in the separation distance between the floating bilayer and the SAM 
(central water thickness), which is independent of PG content in the membrane (Fig. 5D, E, F 
and Table 2). This could be due to the addition of HT61 resulting in a change in the overall 
charge of the bilayer by partitioning into the membrane and neutralising the anionic charge of 
d62DPPG present in both leaflets and therefore eliciting a decrease in the central water 
thickness due to reduced repulsions. Additionally, there is no decrease in the bilayer 
fluctuations, suggesting that the change in central water thickness after addition of HT61 is 
more likely due to a reduced electrostatic contribution, and not a reduction in Helfrich type 
steric repulsion between the two surfaces [41].  
The addition of the first injection of HT61 to bilayers containing only 25% d62 DPPG resulted 
in a thinning of the bilayer by ~6 Å a phenomenon which has previously been observed using 
NR for bilayers composed of similar PC/PG ratios upon challenge with the antimicrobial 
peptide aurein [42].  Overall the most significant effect of HT61 challenge on the lipids in the 
bilayer is evident in the increase in both APM and percentage tail hydration, indicating that 
material was lost from the bilayer and replaced by the solvent (Table 2). Since the two doses 
of HT61 led to similar effects, with an increase in magnitude with each addition of the drug, 
this provides the best evidence for a structural change in the bilayer directly induced by the 
drug. Increasing the proportion of d62DPPG in the bilayer apparently resulted in further 
structural disruption following exposure to HT61. With respect to the derived parameters, the 
trend of increasing percentage tail hydration would again suggest that the coverage of the 
floating bilayer is decreasing and thus that exposure to the drug results in loss of material 
through structural damage to the system. At 75% anionic lipid content the magnitude of the 
HT61 structural effects upon the floating bilayer was at its greatest. Here, the second addition 
of HT61 seems to result in an almost total loss of the floating bilayer, with an apparent final 
coverage of only 30%. It should be noted that the difference between the raw data and the 
model fits in the H2O, SMW and D2O contrasts following challenge with HT61 and the 
higher error in the membrane hydration after addition of the drug results from the significant 
disruption of the bilayer, the model used to fit these data finds it difficult to constrain when 
the bilayer is almost completely removed. However, the structural trend is nevertheless quite 
clear; the introduction of HT61 to the bilayers leads to the removal of lipids from the 
membrane and significant disruption at magnitudes which directly correlate with the amount 
of PG in the membrane. 
DISCUSSION 
Direct action on bacterial membranes has been implicated as the primary mode of action for a 
number of different antimicrobials, including chlorhexidine,[16] daptomycin[15] and 
telavancin.[17] Previous investigations into these membrane-active antimicrobials have 
typically used antimicrobial concentrations 1 to 8 times the MIC [15, 17, 43, 44], however in this 
study we have used concentrations above and below the MIC of HT61 towards S. aureus to 
investigate the true level of membrane-activity of HT61 compared to other membrane-active 
antimicrobials. All assays used for measuring membrane damaging effects were run over a 
short time frame [14] as membrane damage over a longer time frame may be due to a side 
effect of an alternative mode of action. 
Previous studies of daptomycin [15, 43], ceragenins[13] and telavancin[17] have shown that they 
are able to depolarise Gram positive bacterial membranes and elicit the release of 
intracellular components, such as K+ and ATP, in a concentration-dependent manner. As 
previously shown by Castillo et al. [16] chlorhexidine increased the permeability of 
logarithmic phase S. aureus membranes, leading to depolarisation and release of ATP. In this 
study, we found that not only did depolarisation and ATP release occur in a concentration 
dependent manner in logarithmic S. aureus, but that this also occurs in stationary phase cells, 
and we were able to determine the initial rate at which depolarisation occurred. HT61’s 
ability to disrupt and increase the permeability of the membrane, similar to other membrane-
active antimicrobials, was confirmed by the rapid, concentration dependent depolarisation of 
S. aureus membranes and the significant release of ATP, to a greater degree than 
chlorhexidine. HT61’s superior interaction with non-multiplying bacteria, proposed by Hu et 
al. [1] was also confirmed due to a faster rates of depolarisation and larger ATP release at the 
same concentrations. It is tempting to speculate that this is due to a lack of upregulated 
membrane defences in the stationary phase cells. 
The results of this study suggest that the activity of both chlorhexidine and HT61 was 
superior when the cells were in stationary phase. The S. aureus membrane is mainly 
comprised of three phospholipids, the anionic lipids PG and CL, and the cationic lipid L-PG 
[45, 46]. It has been previously suggested that chlorhexidine non-specifically targets anionic 
lipids in the membrane [47] as the higher abundance of the anionic lipid PG in stationary phase 
S. aureus results in an increase in activity of chlorhexidine on the membrane. L-PG is 
synthesised by the addition of lysine onto a PG lipid by the enzyme MprF [48, 49], encoded by 
the mprF gene. mprF is strongly expressed in logarithmic phase S. aureus but downregulated 
in stationary phase S. aureus [23] due to a change in metabolic activity when S. aureus moves 
from the exponential phase to the stationary phase. This results in a higher abundance of 
anionic lipids in the stationary phase membranes. From the evidence of this study, the effect 
of HT61 on the membranes of S. aureus in two different growth phases seems to be similar to 
that of chlorhexidine, therefore, it is proposed that HT61 also non-specifically targets the 
anionic lipid in a membrane. 
The extent to which HT61 alters and ultimately disrupts lipid membrane structure appears to 
be directly proportional to their anionic lipid content, suggesting that Coulombic forces are 
the main drivers of the drug-membrane interaction. The evident ability of HT61 to cause 
major damage to the membrane by destroying membrane integrity, indicates that the 
hydrophobic properties of the drug also constitute an essential factor for its membrane-
activity. The results reported in this study offer some insight into the various stages involved 
in structural changes induced by HT61 upon challenge to susceptible lipid bilayers.  
From the results of the Langmuir monolayer experiments, it is evident that HT61 is not only 
attracted to monolayers containing anionic lipids, but it also readily partitions into these 
monolayers. The lack of interaction observed with the POPC monolayers reliably 
demonstrates that net neutral lipids elicit no such attraction. It is interesting to note that a 
similar partitioning study examining the interaction between chlorhexidine and DPPC 
monolayers observed an increase of ~5 mN/m [47], suggesting that the biocide has some 
interaction with the interfacial region PC membranes, an observation corroborated by neutron 
diffraction studies on PC bilayers [50]. The minimal and gradual increase in surface pressure 
observed in the case of the mammalian membrane mimetic POPC/Chol monolayer may have 
arisen due to monolayer packing inconsistencies caused by the inclusion of the sterol, which 
would be likely to allow some degree of hydrophobic interaction with the drug. Since this is 
negligible compared to the rapid and strong interaction observed in the POPC/POPG which 
were of comparable magnitude to surface pressure changes observed for chlorhexidine and 
daptomycin interactions with similar lipid monolayers [47, 51], the presence of anionic lipid is 
clearly the major determinant for HT61 binding and partitioning and provided the rationale 
for not continuing with the POPC and POPC/Chol systems in subsequent experiments. The 
structural consequences of HT61 partitioning into PG-containing membranes was observed in 
more detail from our neutron reflectivity studies. 
The NR data shows that prior to exposure to HT61, the separation between SAM and floating 
bilayer (CW thickness) of the three bilayers increased as the content of d62DPPG increased. 
The CW thickness or separation, is maintained by a balance of attractive and repulsive forces 
between the floating bilayer and the al-PC SAM [29]. Van der Waals forces created by 
interaction of the al-PC with the zwitterionic d62DPPC of the bilayer, will create the attractive 
forces bringing the bilayer closer to the SAM. However, the repulsive forces have been 
suggested to be created by one of two ways, either by a hydration force or fluctuation 
pressure [29]. Hydration forces can be created by the protrusion of the lipid headgroups out of 
the bilayer perturbing the water structure at the lipid-water interface or the partial charge 
transfer between polar headgroups with the water molecules [52]. The repulsion caused by 
fluctuation pressure are entropic factors facilitated by membrane undulations (Global 
Roughness), single molecule protrusions and headgroup steric overlap [53-55]. Although the 
overall surface charge of the al-PC SAM can be considered to be neutral due to the 
zwitterionic al-PC monolayer, the different overall negative charges of the three bilayers still 
seem to have been capable of eliciting some charged repulsion between the two layers [56]. 
The addition of HT61 to these membranes showed a consistent reduction in this spacing, it is 
likely that this is due to the removal of charged material from the bilayer, resulting in 
significant disruption of the membrane, increasing the area per molecule and reducing the 
repulsive contribution from the surface. 
As expected, the packing and organisation of the lipids within each bilayer varied between 
the three different ratios of d62DPPC and d62DPPG, most notable was the inferred thinning of 
the bilayer as the amount of d62DPPG present in the bilayer increased. This suggests that as 
the content of d62DPPG increased there was some degree of interdigitation of the two leaflets 
due to the charged lateral repulsion between anionic head groups of d62DPPG, 
[57, 58] which 
seems likely as a DPPC-only fluid bilayer has a thickness of 38 Å, [59] whereas both the 50:50 
and 25:75 bilayers were thinner. The apparent interdigitation between the two leaflets may 
have resulted in a decrease in the APM, but the high d62DPPG content in the 25:75 bilayer 
leads to some charged lateral repulsion, slightly increasing the APM in comparison to the 
50:50 bilayer [57].  
As the bilayers were very tightly packed, resulting in a low APM and percentage solvent in 
each prior to challenge with the drug, it is possible to infer that some gross membrane 
damage occurs as a result of interaction with HT61. As the d62DPPG content and 
concentration of HT61 increased, the bilayer was more severely affected, resulting in a 
significant reduction in floating membrane coverage. This can be interpreted as a loss of 
bilayer lipid due to the membrane damaging effect of the drug. Following the second addition 
of HT61 to the 25:75 d62DPPC/d62DPPG bilayer the damage appears much more extensive, 
with complete destruction of the bilayers containing more charged material.  
The neutralisation of the anionic lipids within the inner leaflet of the bilayer, resulting in a 
decrease in the separation distance between the SAM and the floating bilayer, suggests that 
not only does HT61 partitions into and disrupt the membrane but may also translocate across 
the bilayer. Whether or not such a proposed translocation can occur in lipid bilayers of a 
more complex biomimetic composition than our simplified binary mixture model (i.e. 
including LPG and CL), will need to be examined in order to obtain more compelling 
evidence of the overall mechanism of the drug’s action against bacterial cells. However it 
could be that HT61’s membrane activity is only an initial mode of action and that it may have 
a second target within the cell itself, although this would not explain the rapid bactericidal 
activity of the drug [1] and this currently remains a speculative assumption which warrants 
further investigation. 
CONCLUSIONS 
Cationic HT61 is attracted to negatively charged bilayers, partitioning into them (potentially 
translocating across the membrane) and causing structural changes which result in the loss of 
membrane integrity leading to depolarisation, and ultimately severe membrane damage which 
elicits the release of ATP. The action of HT61 on the bilayer is dependent on its 
concentration and the amount of anionic lipid present, as increasing the phosphatidylglycerol 
content elicits a more significant loss of material and catastrophic damage to PC/PG mixed 
bilayers. 
SUPPORTING INFORMATION 
Figure S1 Initial rate of depolarisation over the first minute of both HT61 (filled triangles) 
and chlorhexidine (filled squares) plotted against drug concentration for logarithmic phase 
daptomycin resistant S. aureus. Error bars represent the standard error of the mean (n=3). The 
curves are fitted with the sigmoidal Hill function described in eqn 6. The kinetic parameters 
obtained from the curve fitting were in the case of HT61; Vdepmax 11.8 s
-1, Km 5.2 μg/ml and 
for chlorhexidine; Vdepmax 4.7 s
-1, Km 25.9 μg/ml. 
Table S1 Parameters of the characterisation of the three SAM layers (indicating the specific 
floating bilayer with which they were associated) obtained from their fitted reflectivity 
profiles. 
Figure S2 Fitted neutron reflectivity curves and derived SLD profiles for the SAM and 
floating d62DPPC/d62DPPG [75:25] bilayer pre and post addition of HT61. 
Figure S3 Fitted neutron reflectivity curves and derived SLD profiles for the SAM and 
floating d62DPPC:d62DPPG [50:50] bilayer pre and post addition of HT61. 
Figure S4 Fitted neutron reflectivity curves and derived SLD profiles for the SAM and 
floating d62DPPC:d62DPPG [25:75] bilayer pre and post addition of HT61. 
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Tables 
Table 1 Kinetic parameters derived from the curve fitting functions applied to air/water 
interface monolayer surface pressure changes induced by interaction with HT61 following 
subphase injection.  
Monolayer ΔΠmax 
(mN/m) 
t50 (s) Hill coefficient R2 
POPC ~0.4* - - - 
POPC/Chol 2.9 39.9 1.04 0.97 
POPC/POPG (0 – 35 s) 5.4 15.5 1.40 0.99 
POPC/POPG (17 – 300 s) 13.7 58.5 8.77 0.99 
*Mean value obtained from the curve in Figure 1.  
Table 2 Parameters of the characterisation of the three d62DPPC/d62DPPG bilayers obtained 
from the fitted reflectivity profiles and associated SLD profiles, prior to challenge with HT61 
and after the first and second additions of HT61. 
Data fitting 
parameters 
d62DPPC/d62DPPG Bilayer Composition (mol%) 
[75:25] [50:50] [25:75] 
Alone HT61 (1) HT61 (2) Alone HT61 (1) HT61 (2) Alone HT61 (1) HT61 (2) 
CW thickness (Å) 17.7  3.3 11.7  1.7 28.6  3.2 83.5  4.5 55.6  5.3 27.5  9.3 113.4  8.2 62.6  5.1 67.1  5.2 
Bilayer APM (Å2) 102.9  3.6 112.3  2.2  118.6 3.9 90.6  4.0 106.9  3.8 103.1  7.1 97.4  4.4 119.9  3.2 340  100 
H2O/head 34.8  5.8 21.4  0.6 20.7  3.9 13.3  1.7 23.9  9.8 34.4  8.4 4.9  3.1 39.6  5.2 39.3  9.1 
H2O/tail 0.6  2.1 10.0  0.8 20.9  3.8 0.0  4.0 16.9  4.5 28.6  3.9 0.0  1.8 20.6  4.4 70.7  20.2 
Global roughness 
(Å) 
34.4  1.8 34.7  1.3 23.6  1.1 22.5  1.1 18.0  2.5 27.5  4.5 26.5  1.1 26.4  2.1 40.0  9.7 
Local roughness 
(Å) 
4.4  2.7 1.9  1.1 2.5  0.3 1.0  4.5 0.2  3.6 1.1  4.8 0.3  1.0 0.5  2.1 4.1  4.0 
*Layer thickness 
(Å) 
44.4  3.0 38.4  1.2 41.6  3.4 35.6  4.4 45.6  4.4 60.2  7.0 28.0  2.6 50.4  3.8 26.6  8.1 
*Tail % hydration 2.0  6.5 25.2  10.2 41.3  32.4 0.0  11.9 36.2  26.3 49.0  47.6 0.0  5.7 49.9  32.3 70.4  100 
*Parameters derived from the fitted models. 
 
 
 
 
 
 
 
 
 Figure legends 
Figure 1: Increase in fluorescence of DiSC3(5) dye from a (A) logarithmic and (B) stationary 
phase culture of S. aureus with an OD600 of 0.05 after exposure to various concentrations (32, 
16, 8, 4, 2, 1, 0.5 and 0 µg/ml) of HT61 (filled triangles), chlorhexidine (filled squares) and 
penicillin G (filled circles) (5 mM HEPES 5 mM Glucose (pH 7.2)) for 20 minutes. Error 
bars represent the standard error of the mean (n=3). 
Figure 2: Initial rate of depolarisation over the first minute of both HT61 (filled triangles) 
and chlorhexidine (filled squares) plotted against drug concentration for (A) logarithmic and 
(B) stationary phase S. aureus. Error bars represent the standard error of the mean (n=3).  
Figure 3: Percentage ATP release from (A) logarithmic and (B) stationary phase S. aureus 
(OD600 0.2) after 20 minutes exposure to HT61 (filled triangles), chlorhexidine (filled 
squares) and penicillin G (filled circles). Error bars represent the standard error of the mean 
(n=3).  
Figure 4 Changes in air/water interface lipid monolayer surface pressures (n = 3  s.d.) in 
response to subphase injection of HT61 (~9 ug/ml), for monolayers composed of POPC 
(black circles), POPC/Chol [75:25] (brown squares) and POPC/POPG [75:25] (dark green 
diamonds). The solid lines represent curves fitted to the data using a three-parameter Hill 
function (light green line) for the POPC/Chol monolayer or a piecewise fitting using both a 
three-parameter Hill function (0 – 35 s) and a four-parameter sigmoidal function (17 – 300 s) 
(red lines) for the POPC/POPG monolayer. 
Figure 5 Neutron reflectivity curves showing only the modelled fits (A, B, C) and 
corresponding derived SLD profiles (D, E, F) of the SAM and floating bilayer in H2O 
contrast alone for (A, D) the d62DPPC:d62DPPG [75:25] bilayer (χ2 = 119.0), (B, E) the 
d62DPPC:d62DPPG [50:50] bilayer (χ2 = 156.6), and (C, F) the d62DPPC:d62DPPG [25:75] 
bilayer (χ2 = 124.8). For each bilayer composition, the reflectivity from the unchallenged 
bilayers is compared with that obtained after the first and second additions of HT61.  
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Figure S1 Initial rate of depolarisation over the first minute of both HT61 (filled triangles) and chlorhexidine (filled squares) plotted against 
drug concentration for logarithmic phase daptomycin resistant S. aureus. Error bars represent the standard error of the mean (n=3). The 
curves are fitted with the sigmoidal Hill function described in eqn 6. The kinetic parameters obtained from the curve fitting were in the case 
of HT61; Vdepmax 11.8 s-1, Km 5.2 μg/ml and for chlorhexidine; Vdepmax 4.7 s-1, Km 25.9 μg/ml. 
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Table S1 Parameters of the characterisation of the three SAM layers (indicating the specific floating bilayer with which they were 
associated) obtained from their fitted reflectivity profiles. 
Associated 
d62DPPC/d62DPPG bilayer 
Layer of model Thickness 
(Å) 
Roughness 
(Å) 
Hydration (%) 
75:25 Si substrate 
SiO2 
TMPA 
al-PC Chains 
al-PC Heads 
 
5.0 ± 0.3 
14.0 ± 0.8 
31.9 ± 1.0 
9.0 ± 0.0a 
4.0 ± 0.3 
4.0 ± 0.3 
4.0 ± 0.4 
15.8 ± 1.0 
15.8 ± 1.0b 
 
0 ± 3.5 
55.0 ± 0.9 
24.7 ± 0.9 
10.2 ± 0.3 
50:50 Si substrate 
SiO2 
TMPA 
al-PC Chains 
al-PC Heads 
 
16.0 ± 1.4 
5.4 ± 3.3 
23.4 ± 1.1 
9.0 ± 0.0a 
10.0 ± 1.7 
10.0 ± 1.7 
5.0 ± 2.4 
10.5 ± 2.7 
10.5 ± 2.7b 
 
43.8 ± 2.2 
24.6 ± 6.9 
31.7 ± 7.5 
36.1 ± 4.2 
25:75 Si substrate 
SiO2 
TMPA 
al-PC Chains 
al-PC Heads 
 
14.7 ± 0.5 
5.1 ± 2.8 
35.0 ± 3.4 
9.0 ± 0.0a 
8.4 ± 1.4 
8.4 ± 1.4 
4.0 ± 3.0 
19.0 ± 2.1 
19.0 ± 2.1b 
 
45.0 ± 2.5 
60.0 ± 8.2 
30.3 ± 2.1 
37.4 ± 4.2 
aFixed value according to Hughes et al. (Hughes et al. 2008) 
 bFixed at the same value as the chain roughness. 
 
 
 
 
 
 S4 
 
 
 
Figure S2 Fitted neutron reflectivity curves (A, B, C) and derived SLD profiles (D, E, F) for the SAM and floating d62DPPC/d62DPPG 
[75:25] bilayer (A & D) pre-addition of HT61, (B & E) after the first addition of HT61 and (C & F) after the second addition of HT61.  The 
Chi squared value for all three fits was 119. 
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Figure S3 Fitted neutron reflectivity curves (A, B, C) and derived SLD profiles (D, E, F) for the SAM and floating d62DPPC:d62DPPG 
[50:50] bilayer (A & D) pre-addition of HT61, (B & E) after the first addition of HT61 and (C & F) after the second addition of HT61.  The 
Chi squared value for all three fits was 156.6. 
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Figure S4 Fitted neutron reflectivity curves (A, B, C) and derived SLD profiles (D, E, F) for the SAM and floating d62DPPC:d62DPPG 
[25:75] bilayer (A & D) pre-addition of HT61, (B & E) after the first addition of HT61 and (C & F) after the second addition of HT61.  The 
Chi squared value for all three fits was 124.8. 
 
